Children’s Hospital Los Angeles paused the use of Sarepta Therapeutics Inc.’s gene therapy for Duchenne muscular dystrophy in the wake of rising safety concerns about liver toxicity, adding to mounting challenges for the drugmaker.

Children's Hospital Los Angeles (CHLA) is launching the first sleep registry in the country for children using Apple Watch as well as a new data collection app called WISE-HARE, or "Wearable Intelligent Sensor Enhancement Home Apnea Risk Evaluation.

Children's Hospital Los Angeles paused Sarepta's Elevidys gene therapy after FDA flagged safety issues, including deaths in non-ambulatory patients.